Related Experiment Video
Updated: Jun 5, 2026

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
Published on: March 18, 2021
Mechanisms of epileptogenesis and potential treatment targets
Asla Pitkänen1, Katarzyna Lukasiuk
1Department of Neurobiology, A I Virtanen Institute for Molecular Sciences, University of Eastern Finland, and Department of Neurology, Kuopio University Hospital, Kuopio, Finland. asla.pitkanen@uef.fi
Abstract:
Prevention of epileptogenesis after brain trauma is an unmet medical challenge. Recent molecular profiling studies have provided an insight into molecular changes that contribute to formation of ictogenic neuronal networks, including genes regulating synaptic or neuronal plasticity, cell death, proliferation, and inflammatory or immune responses. These mechanisms have been targeted to prevent epileptogenesis in animal models. Favourable effects have been obtained using immunosuppressants, antibodies blocking adhesion of leucocytes to endothelial cells, gene therapy driving expression of neurotrophic factors, pharmacological neurostimulation, or even with conventional antiepileptic drugs by administering them before the appearance of genetic epilepsy. Further studies are needed to clarify the optimum time window and aetiological specificity of treatments. Questions related to adverse events also need further consideration. Encouragingly, the recent experimental studies emphasise that the complicated process of epileptogenesis can be favourably modified, and that antiepileptogenesis as a treatment indication might not be an impossible mission.
Insights
Preventing epileptogenesis after brain trauma is challenging but achievable. Experimental studies show targeting molecular pathways can favorably modify seizure development, offering hope for new antiepileptogenesis treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Epileptogenesis following brain trauma remains a significant unmet medical challenge.
- Molecular profiling reveals key mechanisms in ictogenic network formation, including plasticity, cell death, and inflammation.
- Understanding these pathways is crucial for developing targeted interventions.
Purpose of the Study:
- To review current strategies for preventing epileptogenesis after brain injury.
- To explore the potential of targeting molecular mechanisms involved in seizure development.
- To assess the efficacy of various therapeutic approaches in preclinical models.
Main Methods:
- Review of recent molecular profiling studies and preclinical research.
- Analysis of therapeutic interventions targeting identified molecular pathways.
- Evaluation of experimental data from animal models of post-traumatic epilepsy.
Main Results:
- Favorable effects observed with immunosuppressants, anti-leukocyte adhesion antibodies, and gene therapy.
- Pharmacological neurostimulation and early administration of antiepileptic drugs show promise.
- Experimental studies demonstrate that epileptogenesis can be favorably modified.
Conclusions:
- Targeting molecular mechanisms offers a viable strategy for antiepileptogenesis.
- Further research is needed to optimize treatment timing and specificity.
- Antiepileptogenesis represents a promising, albeit complex, therapeutic goal.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists
Epilepsy ll: Types
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

